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Abstract
Aims/hypothesis—Although the Diabetes Prevention Program (DPP) established lifestyle 
changes (diet, exercise and weight loss) as the ‘gold standard’ preventive therapy for diabetes, the 
relative contribution of exercise alone to the overall utility of the combined diet and exercise effect 
of DPP is unknown; furthermore, the optimal intensity of exercise for preventing progression to 
diabetes remains very controversial. To establish clinical efficacy, we undertook a study (2009 to 
2013) to determine: how much of the effect on measures of glucose homeostasis of a 6 month 
programme modelled after the first 6 months of the DPP is due to exercise alone; whether 
moderate- or vigorous-intensity exercise is better for improving glucose homeostasis; and to what 
extent amount of exercise is a contributor to improving glucose control. The primary outcome was 
improvement in fasting plasma glucose, with improvement in plasma glucose AUC response to an 
OGTT as the major secondary outcome.
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Methods—The trial was a parallel clinical trial. Sedentary, non smokers who were 45–75 year 
old adults (n=195) with elevated fasting glucose (5.28–6.94 mmol/l) but without cardiovascular 
disease, uncontrolled hypertension, or diabetes, from the Durham area, were studied at Duke 
University. They were randomised into one of four 6 month interventions: (1) low amount (42 kJ 
kg body weight−1 week−1 [KKW])/moderate intensity: equivalent of expending 42 KKW (e.g. 
walking ~16 km [8.6 miles] per week) with moderate-intensity (50% peak V̇O2reserve) exercise; (2) 
high amount (67 KKW)/moderate intensity: equivalent of expending 67 KKW (~22.3 km [13.8 
miles] per week) with moderate-intensity exercise; (3) high amount (67 KKW)/vigorous intensity: 
equivalent to group 2, but with vigorous-intensity exercise (75% peak V̇O2reserve); and (4) diet 
+ 42 KKW moderate intensity: same as group 1 but with diet and weight loss (7%) to mimic the 
first 6 months of the DPP. Computer-generated randomisation lists were provided by our 
statistician (GPS). The randomisation list was maintained by LHW and CAS with no knowledge 
of or input into the scheduling, whereas all scheduling was done by LAB, with no knowledge of 
the randomisation list. Subjects were automatically assigned to the next group listed on the 
randomisation sheet (with no ability to manipulate the list order) on the day that they came in for 
the OGTT, by LHW. All plasma analysis was done blinded by the individuals doing the 
measurements (i.e. lipids, glucose, insulin). Subjects and research staff (other than individuals 
analysing the blood) were not blinded to the group assignments.
Results—Number randomised, completers and number analysed with complete OGTT data for 
each group were: low-amount/moderate-intensity (61, 43, 35); high-amount/moderate-intensity 
(61, 44, 40); high-amount/vigorous-intensity (61, 43, 38); diet/exercise (54, 45, 37), respectively. 
Only the diet and exercise group experienced a decrease in fasting glucose ( p<0.001). The means 
and 95% CIs for changes in fasting glucose (mmol/l) for each group were: high-amount/moderate-
intensity −0.07 (−0.20, 0.06); high-amount/vigorous 0.06 (−0.07, 0.19); low-amount/moderate 
0.05 (−0.05, 0.15); and diet/exercise −0.32 (−0.46, −0.18). The effects sizes for each group (in the 
same order) were: 0.17, 0.15, 0.18 and 0.71, respecively. For glucose tolerance (glucose AUC of 
OGTT), similar improvements were observed for the diet and exercise (8.2% improvement, effect 
size 0.73) and the 67 KKW moderate-intensity exercise (6.4% improvement, effect size 0.60) 
groups; moderate-intensity exercise was significantly more effective than the same amount of 
vigorous-intensity exercise (p<0.0207). The equivalent amount of vigorous-intensity exercise 
alone did not significantly improve glucose tolerance (1.2% improvement, effect size 0.21). 
Changes in insulin AUC, fasting plasma glucose and insulin did not differ among the exercise 
groups and were numerically inferior to the diet and exercise group.
Conclusions/interpretation—In the present clinical efficacy trial we found that a high amount 
of moderate-intensity exercise alone was very effective at improving oral glucose tolerance despite 
a relatively modest 2 kg change in body fat mass. These data, combined with numerous published 
observations of the strong independent relation between postprandial glucose concentrations and 
prediction of future diabetes, suggest that walking ~18.2 km (22.3 km prescribed with 81.6% 
adherence in the 67 KKW moderate-intensity group) per week may be nearly as effective as a 
more intensive multicomponent approach involving diet, exercise and weight loss for preventing 
the progression to diabetes in prediabetic individuals. These findings have important implications 
for the choice of clinical intervention to prevent progression to type 2 diabetes for those at high 
risk.
Trial registration—ClinicalTrials.gov NCT00962962
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Introduction
Type 2 diabetes is one of the leading health threats in the developed world. The landmark 
Diabetes Prevention Program (DPP) established lifestyle changes (diet, exercise and weight 
loss) to be the ‘gold standard’ therapy for prevention of diabetes [1]. However, efficient and 
effective implementation of lifestyle interventions to prevent diabetes requires the following 
issues to be established: the relative contribution of exercise alone to the overall diet and 
exercise effect of DPP; whether moderate- or vigorous-intensity exercise is better for 
improving glucose homeostasis; and whether the amount of exercise is an important variable 
for improving glucose control. Resolution of these issues is important for implementation of 
the optimal lifestyle programme for prevention of diabetes. If providers in busy clinical 
practices find it necessary and effective to counsel only one component of a lifestyle 
intervention at a time and/or patients are more likely to undertake a single lifestyle change at 
a time (e.g. an exercise-only programme), it is critical to understand how much of the 
beneficial effects of the diet and exercise programme they are likely to expect.
The most efficacious exercise intensity for control of glucose metabolism remains 
controversial. Many studies suggest that moderate-intensity exercise may be more beneficial 
than vigorous-intensity exercise for some outcomes [2–13]. In STRRIDE (Studies of 
Targeted Risk Reduction Interventions through Defined Exercise), we observed that 
moderate-intensity training was more effective at improving insulin sensitivity [2, 3], the 
metabolic syndrome [6], triacylglycerols [4, 13] and beta cell function [5] than an energy 
equivalent amount of vigorous-intensity exercise training. In contrast, one recent study [14] 
implies that vigorous-intensity exercise is superior to moderate-intensity exercise for glucose 
control. Few studies have tested head to head the effects of exercise intensity for glucose 
homeostasis while simultaneously controlling for total exercise energy expenditure or the 
effect of exercise amount while controlling for intensity.
To better understand the exercise benefit relative to a combined exercise/diet programme, 
and to explore the independent influence of exercise intensity and amount for improvement 
in glucose homeostasis in those at risk for diabetes, we undertook STRRIDE-PD (STRRIDE 
in individuals with Prediabetes; i.e., in individuals at risk for progression to diabetes with 
fasting plasma glucose of 5.3 to 6.9 mmol/l on two consecutive occasions, separated by at 
least one week), a clinical efficacy trial. The study goals meant that the study design 
incorporated qualitative comparisons with a diet and exercise programme modelled after the 
first 6 months of the DPP (rather than with a non-exercising control group). To investigate 
the role of intensity and amount, direct statistical comparisons were made among the 
exercise-only groups. Based on our previous observations—and perhaps contrary to 
‘common wisdom’—we hypothesised that: a high percentage of the diet and exercise effect 
on measures of glucose control would be achieved with a high amount of moderate-intensity 
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exercise; moderate-intensity exercise would be superior to vigorous-intensity exercise 
training, controlling for amount; and a high amount would be superior to a low amount of 
moderate-intensity exercise.
We are not aware of any other studies that have studied the effects of different intensities of 
exercise training controlling for total energy expenditure on oral glucose tolerance in 
individuals with prediabetes.
Methods
Study design
The protocol was approved by the Duke Institutional Review Board and informed written 
consent obtained. Participants were recruited continuously between 2009 and 2012 from 
Durham (NC, USA) and the surrounding area. We randomised 195 sedentary 45–75 year old 
adults with BMI 25–35 kg/m2. A statistician (GPS) provided four computer-generated 
randomisation lists by sex/race (white women, white men, non-white women, non-white 
men) in blocks of 12. The randomisation lists were maintained by LHW and CAS with no 
knowledge of, and no input into, scheduling, whereas all scheduling was done by LAB with 
no knowledge of the randomisation list. Participants were automatically assigned to the next 
group on the randomisation list (with no ability to manipulate the list order) on the day that 
they came in for their glucose tolerance test by LHW. Recruited individuals had two 
consecutive fasting glucoses between 5.28 and 6.94 mmol/l taken 1 week apart. Exclusion 
criteria included smoking, diabetes, uncontrolled hypertension, musculoskeletal disorders 
and cardiovascular disease. The study design was listed on clinicaltrials.gov (registration 
number NCT00962962) prior to initiation of the study.
Interventions
Participants were randomised into one of four 6 month intervention groups consisting of 
exercise predominantly on treadmills, but also elliptical trainers, rowing and cycle 
ergometers: (1) low amount/moderate-intensity exercise (42 kJ kg body weight−1 week−1 
[KKW]), exercise energy expenditure of 42 KKW at 50% V̇O2reserve; (2) high amount/
moderate-intensity exercise (67 KKW), 67 KKW at 50% V̇O2reserve; (3) high amount/
vigorous-intensity exercise (67 KKW), 67 KKW at 75% V̇O2reserve; and (4) clinical lifestyle 
intervention (diet + exercise): 42 KKW at 50% V̇O2reserve plus a diet designed to reduce 
body weight by 7% over 7 months.
V̇O2peak was determined by a graded maximal treadmill test which started at 3 mph/0% 
grade and then increased speed and/or grade such that the metabolic demand increased at 
approximately 3.5 ml kg−1 min−1 per stage. V̇O2reserve (50% or 75%) was chosen for the 
exercise prescription and defined as 0.50 or 0.75 × (V̇O2peak – resting V̇O2) + resting V̇O2. 
Energy (kJ) expended during exercise per week was determined based on the per cent of 
V̇O2reserve only, without including the resting V̇O2. This is the most accurate way to 
compare groups exercising at differing intensities [15]. The heart rate at any given intensity 
was determined by a progressive exercise test with gas exchange. Exercise frequency was up 
to the participant; a frequency was recommended with the goal of a 60 min maximum for a 
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single session. Participants were asked to exercise under supervision on at least 2 days per 
week; at these sessions, we downloaded their heart rate monitors and discussed training 
progress. Participants were allowed to exercise at our fitness centre without supervision on 
the other days.
A 10 week ramp period gradually increased exercise amount to the prescribed level. 
Exercise intensity was maintained by using a target heart rate range confirmed by a 
submaximal oxygen consumption testing at the midpoint of the exercise programme. Thus, 
as fitness increased, participants worked harder to achieve a similar heart rate, which 
required reducing weekly exercise time to maintain constant weekly energy expenditure. All 
exercise was verified by Garmin (Olathe, KS, USA) downloadable heart rate monitors. 
Maximal exercise duration was capped at 6 h/week to limit participant burden—women have 
lower V̇O2peak so had to exercise longer to expend the same total energy per week, and we 
believed this would have placed a disproportionate time burden on women and reduced 
compliance. Similarly, participants with low exercise capacity had to exercise for a longer 
time to achieve the desired weekly energy expenditure.
Participants randomised to the diet and exercise group received an intervention modelled 
after the DPP [1], designed to achieve a 7% weight reduction via energy-intake restriction, 
low-fat diet and exercise. Following four initial counselling sessions, participants attended 
12 bi-weekly intensive group sessions adapted from the DPP manual.
Body composition
Body composition was determined using air displacement plethysmography (BOD POD Life 
Measurement, Concord, CA, USA).
OGTT and lipids
Before training and between 16 and 24 h after the last exercise training bout, after a 10 h 
fast, participants drank a 75 g glucose drink with blood samples taken at 0, 30, 60, 90 and 
120 min. Participants were asked to eat their normal diet the evening before each test. 
Glucose, total cholesterol, HDL-cholesterol and triacylglycerol were measured with a 
Beckman-Coulter DxC600 clinical analyser (Brea, CA, USA). Insulin was measured by 
electrochemiluminescent plate assay, Meso Scale Discovery (Gaithersburg, MD, USA). 
AUCs of the glucose and insulin curves were calculated by the trapezoid method. Matsuda 
index was calculated as described in Matsuda and Defronzo [16].
Outcomes
The primary outcome for this trial was fasting glucose. Other strong secondary outcomes 
included other measures of glucose control: specifically, changes in glucose tolerance 
(AUCs for glucose, and 1 h and 2 h glucose values), fasting insulin and insulin AUC. 
Additional outcomes included measures of cardiometabolic health (lipids, waist 
circumference, cardiorespiratory fitness, body weight and body composition).
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Sample size
Based on our experience from STRRIDE [2, 3], we estimated we would need 35–45 
finishers per group to have adequate power to detect significant changes within groups for 
cardiometabolic variables and that this sample size would provide enough power to detect 
differences between groups. While neither we nor others have specific data on the 
improvement in glucose tolerance expected for different exercise intensities, the study by 
Houmard et al [3] had adequate power to detect a difference in insulin sensitivity between 
the low amount/moderate intensity and the low amount/vigorous intensity groups (p<0.05), 
which strongly supported an intensity effect (i.e. moderate intensity was superior). While we 
hoped to finish with 50 participants in each group, funding cuts meant we had to stop just 
short of that goal (within 10%).
Statistical analyses
A priori, the study was designed to make only qualitative comparisons (per cent 
comparisons, non-statistical) among the three exercise-only groups when compared with the 
diet, exercise and intentional weight loss group; therefore, there was no inactive control 
group in this study. To address the question of how the exercise-only interventions compared 
with the lifestyle intervention, percentages of the effect observed with each of exercise-only 
intervention relative to that obtained with the diet-exercise group is reported. This is justified 
based on the findings of DPP, in which the lifestyle intervention was superior to metformin 
and control [1]; therefore, it was not clinically useful to compare the effects of our 
interventions with a control.
The primary quantitative comparisons were assessing the independent effects of exercise 
intensity and amount on outcomes. The study was powered for two statistical comparisons: 
(1) an exercise-intensity effect was tested by comparing the two 67 KKW groups (high 
amount/moderate vs high-amount/vigorous); and (2) an exercise amount effect was tested by 
comparing the two moderate-intensity groups. Group comparisons were performed with 
ANCOVA and included baseline values as covariates (Statview, Cary, NC, USA). Post-hoc 
analyses were confined to the two comparisons among the exercise groups (of intensity and 
amount): the critical α was p<0.025 to account for two major comparisons. To determine 
whether within-group changes (i.e. not between groups) were significant, we used two-tailed 
paired (pre-intervention vs post-intervention) t tests, where critical α was p<0.05. The 
analyses presented were performed ‘per protocol’.
Results
Figure 1 shows the flow diagram of screening, randomisation and dropout numbers. 
Demographic baseline characteristics and exercise prescriptions are presented in Table 1. 
Baseline values and change scores for body composition and metabolic variables are shown 
in Table 2. The two high-amount groups were significantly older than the low-amount and 
diet/exercise groups. There were no other baseline differences between groups for variables 
in Tables 1 or 2. Participants who dropped out were heavier (92.2 vs 87.2 kg), had greater fat 
mass (38.0 vs 35.5 kg) and larger waist circumferences (102.8 vs 99.2 cm) compared with 
the completers at baseline (all p<0.05, data not shown). No other differences between 
Slentz et al. Page 6
Diabetologia. Author manuscript; available in PMC 2017 October 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
completers and dropouts were observed for variables presented in Tables 1 and 2. There 
were no differences for any metabolic outcome variable at baseline between intervention 
groups or between completers and dropouts.
Exercise prescriptions are in Table 1. The time required to expend 67 KKW is based on 
fitness levels (oxygen consumption rate; ml kg−1 min−1; 1 l O2 consumption is roughly 
equivalent to 21 kJ energy use) and exercise training intensity (moderate or vigorous). 
Individuals with lower maximal fitness levels required more time to complete the energy-
expenditure-based exercise prescriptions at either 50% or 75% of this value. While 
energetically equivalent, moderate-intensity exercise appears to improve some key metabolic 
variables more than vigorous-intensity, vigorous-intensity exercise improved fitness levels to 
a greater degree.
Table 2 presents baseline and change scores for key variables. As expected, all groups lost 
weight (though the weight lost by the low amount/moderate intensity group was not 
significant). Also, when expressed in ml kg−1 min−1, the diet/exercise group and both high-
amount exercise groups experienced significant improvements in cardiorespiratory fitness. 
Importantly, this increase in fitness was due entirely to weight loss for the diet/exercise 
group, because when expressed as l/min there was no increase for this group. Changes in 
body composition were greatest for the diet/exercise group; and for the exercise-only groups, 
corresponded to total exercise energy expenditure.
Magnitude of exercise contribution
Only the diet/exercise group experienced significant reductions in fasting glucose (Table 2). 
Diet/exercise also had the most robust effects on fasting insulin, HOMA, Matsuda index and 
insulin AUC. As indicated by changes in insulin AUC and Matsuda index score, all 
interventions improved insulin sensitivity. For improving glucose tolerance, the low amount/
moderate intensity group was half as effective as diet/exercise (53%) and twice as effective 
as the high amount/vigorous intensity group.
Intensity effects
For both the diet/exercise and the high amount/moderate intensity group, changes in glucose 
AUC were similar and quite robust (Fig. 2a). The high amount/moderate-intensity exercise 
achieved 79% of the diet/exercise group (t test for within-group change for high/moderate 
group, p=0.0005; Table 2). The glucose incremental AUC data show that the main difference 
between lifestyle and high amount/moderate was due to the decrease in fasting glucose by 
the lifestyle group. The AUC incremental improvement was actually higher for the high/
moderate group.
In contrast, the high amount/vigorous intensity group experienced a very small, non-
significant, change in glucose AUC (t test, p=0.20). Importantly, the high amount/moderate 
intensity group was statistically superior to the high amount/vigorous group (p=0.0207; 
effect size = 0.445; Fig. 2a). The low amount/moderate intensity group was intermediate 
between the high-amount exercise groups; however, the improvement was not quite 
significant (p<0.10).
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Amount effects
The high amount/moderate intensity group experienced larger quantitative improvements 
than the low amount/moderate-intensity exercise group for most, but not all, of the glucose 
homeostasis variables (Fig. 2a–d, Table 2), although there were no statistically significant 
differences between the two moderate-intensity groups. The effects of the different 
interventions on the glucose and insulin curves are shown in Fig. 3a–d (glucose) and Fig. 
4a–d (insulin). Glucose values at 30, 60 and 90 but not 120 min were significantly improved 
after exercise training in the high amount/moderate intensity group, whereas the reverse 
occurred in the high amount/vigorous intensity group (Fig. 3a). When a separate ANCOVA 
was performed between the high amount/moderate vs high amount/vigorous groups on each 
time point (30, 60, 90 and 120 min) the p values for statistical comparisons at these four 
time points were: 0.035; 0.086, 0.081 and 0.597, respectively. The high amount of moderate-
intensity exercise resulted in significant improvements in glucose at 30 min. Though the 
high amount/vigorous group experienced a significant improvement in glucose at 120 min, 
this improvement was not different from the improvement in the high amount/moderate 
intensity group. As was expected, the largest and most consistently significant improvement 
was observed in the clinical lifestyle group. As illustrated in Fig. 4a–d, all four interventions 
resulted in robust reductions in overall insulin levels and in reductions in insulin at all time 
points.
Discussion
There were two major goals for our study: (1) to determine, in individuals at risk for 
diabetes, what percentage of the ‘gold standard’ effect of diet and exercise can be achieved 
with aerobic exercise alone on glucose homeostasis measures (fasting glucose, oral glucose 
tolerance and measures of insulin sensitivity); and (2) to determine the independent effects 
of exercise intensity and amount on these same measures in individuals at risk of developing 
diabetes. We are not aware of any other studies that have investigated the effects of different 
intensities of exercise training on oral glucose tolerance in individuals with prediabetes. For 
the primary outcome, fasting glucose, there was significant improvement only in the diet and 
exercise group. The exercise-only groups did not experience any change in fasting glucose. 
With respect to glucose tolerance, there were two major findings. First, the effect of a high 
amount/moderate-intensity exercise on glucose tolerance was essentially the same as that of 
the diet/exercise group; this exercise-only group achieved 79% of the improvement in 
glucose tolerance that was obtained with the combined therapy group. Second, high amount/
moderate-intensity exercise robustly improved glucose homeostasis and had a statistically 
superior effect on AUC for glucose during an OGTT compared with the same amount of 
vigorous-intensity exercise.
These observations are remarkable. They confirm and build on our earlier findings regarding 
exercise training intensity effects. In STRRIDE [17], a large randomised controlled trial, we 
observed that, compared with vigorous-intensity exercise, the same amount of moderate-
intensity exercise training led to greater improvements in: insulin sensitivity [2, 3], the 
metabolic syndrome [6], triacylglycerols [13] and beta cell function [5]. That is, while we 
[18] and others have observed that vigorous intensity is clearly superior for improvements in 
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cardiorespiratory fitness, our previous findings, taken together with the current study, 
suggest that moderate-intensity exercise may be better than vigorous-intensity exercise for 
maintaining cardiometabolic health and preventing the development of diabetes in at-risk 
individuals.
Recently, in a large and well-designed exercise study [14], Ross and colleagues reached an 
opposing conclusion that vigorous-intensity exercise outperformed moderate-intensity 
exercise in measures of glucose control; however, most of their observations were 
remarkably similar to those made in our study. In the study by Ross et al, 300 abdominally 
obese individuals unscreened for baseline glucose abnormalities were randomised to high 
amount/vigorous intensity, high amount/moderate intensity, low amount/moderate intensity 
or control group; this was very similar to our study design. In the study by Ross et al, 
changes in waist circumference and the 2 h glucose time point during the OGTT were 
considered primary outcomes. The vigorous intensity/high amount group outperformed the 
controls at the 120 min OGTT glucose time point. The effect for the moderate intensity/high 
amount group was non-significant at this time point; however, direct comparison of intensity 
effects controlling for amount in Ross’s Table 3 reveals that the effects of the high amount/
vigorous and high amount/moderate exercise on 2 h glucose were not different. Inspection of 
our Fig. 3c and Table 2 also reveal that, of the exercise-only interventions, only with 
vigorous-intensity exercise did we observe a significant change in 2 h glucose. One should 
note that in the study by Ross et al, both high-amount groups improved several health-
related measures compared with controls: insulin AUC, Matsuda index, HDL-cholesterol, 
fasting insulin, HOMA, and systolic and diastolic blood pressure (Appendix and Table 3 
from the Ross paper). However, in Ross’s study, only the high amount/moderate-intensity 
exercise (and not vigorous intensity) was significantly different from the control group for 
these measures. Thus, despite some differences in the study population and approach, our 
findings—if not our conclusions—are remarkably concordant with those in the Ross study. 
The exception is a substantial difference with our findings of a significant difference 
between the two high-amount groups on improvement in AUC for glucose. This may be due 
to the different participant populations. In the present study, participants were recruited 
specifically to select for abnormal glucose; in the Ross study, participants were selected for 
abdominal obesity. In summary the outcome of the dispute may depend on which variable is 
chosen as the primary outcome measure.
We conclude that the large improvement in post-load glucose observed with high amount/
moderate-intensity exercise suggests this may be a very effective intervention for reducing 
the risk of diabetes. Several studies have observed that post-load glucose is superior to 
fasting glucose for predicting all-cause mortality, cardiovascular disease incidence and 
mortality, and incident diabetes [19–32]. In the San Antonio Heart Study [32] and the Botnia 
Study [29], 1 h glucose was the best single predictor of incident diabetes, significantly better 
than both fasting and 2 h glucose [30],[29]; this is particularly relevant, as moderate-
intensity exercise appears especially effective at lowering 1 h glucose (Fig. 3a).
The diet/exercise group experienced a robust reduction in fasting glucose, while the 
exercise-only groups had no effect on fasting glucose; this was an expected finding. It is 
intriguing to speculate about the mechanisms mediating this effect. Impaired fasting glucose 
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is generally considered to be indicative of hepatic insulin resistance, whereas impaired 
glucose tolerance is considered to be reflective of peripheral insulin resistance [33]. While 
we did not statistically compare the diet and exercise group with the exercise-only groups, 
the diet and exercise group experienced between 188% and 269% greater improvement in 
the Matsuda index (Table 2) than the exercise-only groups. The Matsuda index includes all 
glucose and insulin values obtained from the 2 h glucose test; thus, the robust improvements 
seen in these individual variables by the diet/exercise group was reflected in the Matsuda 
index.
We were surprised to observe that vigorous-intensity exercise training had no significant 
effect on glucose AUC when measured 16–24 h after the last exercise training bout. While 
this group experienced reductions in insulin AUC, it will be important to understand 
(through future mechanistic studies) why vigorous-intensity training did not improve 
glucose tolerance. Perhaps vigorous-intensity exercise—but not moderate-intensity exercise
—results in increases in glucose counter-regulatory hormones or skeletal muscle adaptations 
to acute exercise that prevent the maximum benefit of training to be accrued between 16 and 
24 h after the last bout of exercise.
It is important to note the limitations of this study. Obtaining a high amount of moderate-
intensity exercise in individuals with low fitness is challenging. Participants in our study 
required, on average, 4.8 h of moderate-intensity exercise (more for women) to expend 67 
KKW. Importantly, the diet part of the diet/exercise weight loss group was much more 
intensive and included many additional one-on-one and small-group interactions; this 
resulted in the lowest dropout rate of all of the groups. We did not control for the greater 
amount of personal contact time received by the diet/exercise relative to the exercise-only 
groups. Finally, we can only infer the effects of the different interventions on true diabetes 
incidence and progression. In reality, only a diabetes outcome study would be able to 
determine whether moderate-intensity exercise is superior to vigorous-intensity exercise in 
the prevention of type 2 diabetes, and whether it is similar to diet/exercise in effectiveness.
In summary, a high amount of moderate-intensity exercise achieved 79% of the glucose-
lowering effect that was experienced by an intensive combined lifestyle intervention 
consisting of diet and exercise designed to effect a 7% weight loss over 6 months. In 
addition, moderate-intensity exercise was significantly superior to the energy-equivalent 
amount of vigorous-intensity exercise for improvements in glucose tolerance. Taken together 
with the numerous findings of strong independent relations between postprandial glucose 
levels and prediction of type 2 diabetes, these observations suggest that a high amount of 
moderate-intensity exercise may be a very effective intervention for preventing progression 
to diabetes in at-risk individuals. However, other than the significant difference in glucose 
tolerance, there were no other significant differences between the moderate- and vigorous-
intensity exercise training groups for any other cardiometabolic health-related variable.
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Fig. 1. 
Screening flowchart
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Fig. 2. 
Changes in glucose AUC (a), insulin AUC (b), fasting glucose (c) and fasting insulin (d) for 
each intervention group. The percentages inside each bar represent the percentage of the 
diet, exercise and intentional weight loss group (lifestyle) that was obtained for that variable, 
with lifestyle represented as 100%. ANCOVA with baseline values as a covariate, with post 
hoc testing between the two groups differing in exercise intensity and between the two 
groups differing in amount (controlling for baseline values) revealed a statistically 
significant difference (*p<0.05 [p=0.0207]) between the high amount/moderate intensity and 
the high amount/vigorous intensity groups for glucose AUC. The improvement in the high 
amount/moderate intensity group was superior to, but not statistically different from, the low 
amount group. Mod, moderate; vig, vigorous
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Fig. 3. 
OGTT glucose curves. The pre- and post-training glucose means and standard error bars are 
plotted for each time point of the OGTT for each group: high amount/moderate intensity (a); 
high amount/vigorous intensity (b); low amount/moderate intensity (c); and clinical lifestyle 
(d). Pre-training data are shown with solid lines, post-training data are shown with dashed 
lines. Significant differences for each within-group time point (pre- vs post-training value) 
were determined by a two-tailed paired t test: *p<0.05; **p<0.01; ***p<0.001
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Fig. 4. 
OGTT insulin curves. The pre-training and post-training insulin means and standard error 
bars are plotted for each time point of the OGTT, for each intervention group: high amount/
moderate intensity (a); high amount/vigorous intensity (b); low amount/moderate intensity 
(c); and clinical lifestyle (d). Pre-training data are shown with solid lines, post-training data 
are shown with dashed lines. Significant differences for each within-group time point (pre- 
vs post-training value) were determined by a two-tailed paired t test: †p<0.10; *p<0.05; 
**p<0.01; ***p<0.001
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